<DOC>
	<DOCNO>NCT00277537</DOCNO>
	<brief_summary>Study assess safety effectiveness 12 week treatment study medication , Bronchitol , subject bronchiectasis ( lung disease patient trap , often infect , thick , sticky mucus ) . Past study show Bronchitol inhalation may help facilitate clearance mucus alter rheology ( make less thick sticky ) , thereby enhance shift stagnant mucus lung . On completion double blind phase , subject opportunity participate 52 week open label phase .</brief_summary>
	<brief_title>Safety Efficacy Bronchitol Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Non cystic fibrosis bronchiectasis Have FEV1 50 % 80 % predict â‰¥1.0L Have chronic sputum production &gt; 10 mL per day majority day 3 month prior study entry Be use hypertonic saline mucolytic pharmacological agent concurrently 4 week prior study entry Have airway hyperresponsiveness define positive Aridol challenge</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Mannitol</keyword>
</DOC>